The mechanisms responsible for transition of CML chronic phase into blast crisis remain poorly understood, although a reasonable assumption is that the unrestrained activity of BCR/ABL in haematopoietic stem/progenitor cells is the primary determinant of disease progression. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.